Navigation Links
Study Finds No Link Between HPV Vaccine and Autoimmune Disorders
Date:1/26/2012

THURSDAY, Jan. 26 (HealthDay News) -- The human papillomavirus (HPV) vaccine Gardasil does not trigger autoimmune disorders such as rheumatoid arthritis, lupus, type 1 diabetes or multiple sclerosis, according to a two-year study that included nearly 190,000 girls and women.

Gardasil is recommended in the United States for girls and young women to protect them against HPV infection, which is the most common sexually transmitted disease in the United States and can lead to cervical cancer. A second HPV vaccine, GlaxoSmithKline's Cervarix, is also approved to prevent infection with the virus.

However, long-standing concerns that the HPV vaccine might trigger autoimmune reactions have led many parents to bar their children from receiving the three-dose vaccine, the study authors pointed out in a news release from Kaiser Permanente.

In the study, which was funded by Gardasil's maker, Merck & Co., researchers analyzed the health records of almost 190,000 females aged 9 to 26 in California who were followed for six months after receiving each dose of Gardasil in 2006-2008.

The Kaiser Permanente researchers said that, compared to females who did not get the shot, vaccinated females did not have higher rates of 16 autoimmune conditions, including lupus, rheumatoid arthritis, Graves' disease, multiple sclerosis, optic neuritis and others.

The study, led by Chun Chao, a research scientist at the Kaiser Permanente department of research and evaluation in Pasadena, Calif., is published in the February issue of the Journal of Internal Medicine.

One expert not connected with the study said the findings were reassuring.

"This study confirms what we had already believed to be true of this vaccine," said Dr. Stephanie Blank, assistant professor in the department of obstetrics and gynecology and director of the gynecologic oncology fellowship at NYU Langone Medical Center in New York City. She believes that "the benefits of the HPV vaccine clearly outweigh the risks. The HPV vaccine gives us a great tool -- a means to actually prevent cervical cancer."

An expert in rheumatology agreed.

"This well-designed study looked at a large number of women who received the human papillomavirus vaccine. There did not appear to be an increased risk of developing autoimmune diseases in those vaccinated," said Dr. Harry Fischer, chief of the division of rheumatology at Beth Israel Medical Center in New York City. "This article speaks to the safety of the vaccine and helps to confirm that it does not contribute to the development of autoimmune diseases," he said.

More information

The U.S. Centers for Disease Control and Prevention has more about HPV vaccines.

-- Robert Preidt

SOURCES: Harry D. Fischer M.D., chief, division of rheumatology, Beth Israel Medical Center, New York City; Stephanie V. Blank, M.D., assistant professor, department of obstetrics and gynecology and director, gynecologic oncology fellowship, NYU Langone Medical Center, New York City; Kaiser Permanente, news release, Jan. 25, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. NIH study shows caffeine consumption linked to estrogen changes
2. Optimal Heart Health Starts Early: Study
3. Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds
4. IH study shows HIV-exposed children at high risk of language delay
5. Many Docs Use Costly MRIs to Diagnose Nerve Condition: Study
6. Queens study shows the rights of people with disabilities are not being promoted
7. Kaiser Permanente study finds Gardasil does not trigger autoimmune conditions after vaccination
8. Avastin, Sutent increase breast cancer stem cells, U-M study shows
9. Gene Mutations May Boost Ovarian Cancer Survival: Study
10. Frying With Olive, Sunflower Oil OK for Heart, Study Finds
11. Treatment of silent acid reflux does not improve asthma in children, NIH study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds No Link Between HPV Vaccine and Autoimmune Disorders
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: